Description
The pre-CTA consultation meeting provides an opportunity for the sponsor to present relevant data, discuss concerns and resolve issues regarding drug development. It also gives Health Canada an opportunity to provide guidance on the acceptability of the proposed trial(s).
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Pre-Clinical Trial Application (CTA) Consultation Meeting | HTML | Open resource | |
| Pre-Clinical Trial Application (CTA) Consultation Meeting | HTML | Open resource |